SCHEMBL4040671

SCHEMBL4040671

CC(=O)c1ccc(C2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3ccccc3N2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 3/20 0.45
EPHX1 P07099 1/20 0.45
TSHR P16473 3/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
THRB P10828 1/20 0.42
BLM P54132 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043049 0.89 SMN1; SMN2 (0.46) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4042940 0.88 TSHR (0.45) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4034540 0.87 DHODH (0.46) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4041199 0.87 SMN1; SMN2 (0.47) NPC1RAB9AEPHX1TSHRLMNA
SCHEMBL4042732 0.86 NR1H4 (0.44) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4039101 0.86 NR1H4 (0.44) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4040005 0.86 KMT2A (0.43) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4037453 0.86 EPHX1 (0.43) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4044939 0.86 NPC1 (0.46) NPC1RAB9AEPHX1TSHRALDH1A1
SCHEMBL4037380 0.85 POLB (0.42) NPC1RAB9AEPHX1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed